Details for Patent: 10,689,346
✉ Email this page to a colleague
Which drugs does patent 10,689,346 protect, and when does it expire?
Patent 10,689,346 protects ORLADEYO and is included in one NDA.
This patent has sixty patent family members in twenty-eight countries.
Summary for Patent: 10,689,346
| Title: | Human plasma kallikrein inhibitors |
| Abstract: | Disclosed are compounds of formula I ##STR00001## as described herein, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also disclosed are pharmaceutical compositions comprising at least one such compound, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity. |
| Inventor(s): | Kotian; Pravin L. (Hoover, AL), Babu; Yarlagadda S. (Birmingham, AL), Wu; Minwan (Vestavia Hills, AL), Chintareddy; Venkat R. (Vestavia Hills, AL), Kumar; V. Satish (Birmingham, AL), Zhang; Weihe (Vestavia, AL) |
| Assignee: | BioCryst Pharmaceuticals, Inc. (Durham, NC) |
| Application Number: | 16/400,798 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,689,346
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-001 | Dec 3, 2020 | RX | Yes | No | 10,689,346 | ⤷ Subscribe | PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER | ⤷ Subscribe | ||||
| Biocryst | ORLADEYO | berotralstat hydrochloride | CAPSULE;ORAL | 214094-002 | Dec 3, 2020 | RX | Yes | Yes | 10,689,346 | ⤷ Subscribe | PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,689,346
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3113772 | ⤷ Subscribe | 301142 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3113772 | ⤷ Subscribe | CA 2021 00040 | Denmark | ⤷ Subscribe |
| European Patent Office | 3113772 | ⤷ Subscribe | PA2021524 | Lithuania | ⤷ Subscribe |
| European Patent Office | 3113772 | ⤷ Subscribe | LUC00233 | Luxembourg | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
